Cargando…
Sacubitril/Valsartan Improves Progression of Early Diabetic Nephropathy in Rats Through Inhibition of NLRP3 Inflammasome Pathway
PURPOSE: Diabetic nephropathy (DN), a global disease, is the leading cause of end-stage renal disease. There is a lack of specific treatment for this disease, and early intervention in disease progression is essential. In this paper, we used a rat model of early diabetic nephropathy to explore the t...
Autores principales: | Pan, Yan, Liu, Lei, Yang, Huijuan, Chen, Weidong, Chen, Zheng, Xu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386175/ https://www.ncbi.nlm.nih.gov/pubmed/35992034 http://dx.doi.org/10.2147/DMSO.S366518 |
Ejemplares similares
-
Sacubitril/Valsartan Alleviates Experimental Autoimmune Myocarditis by Inhibiting Th17 Cell Differentiation Independently of the NLRP3 Inflammasome Pathway
por: Liang, Wei, et al.
Publicado: (2021) -
Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice
por: Li, Xueling, et al.
Publicado: (2020) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts
por: Li, Xiaofei, et al.
Publicado: (2021) -
Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)